Tvardi Therapeutics, Inc. (TVRD) stock
TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.01−0.09 (-8.18%)
Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%
Tvardi Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Tvardi Therapeutics's EV/EBITDA was 67.4× on Jan 31, 2022, against 313.0× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 67.4× | −3.9 |
| 2021 | Dec 31, 2021 | 71.4× | −241.6 |
| 2014 | Apr 30, 2014 | 313.0× | – |
See a number that looks wrong?